Dichloromethane → 4-(4-Chloro-2-fluoroanilino)-6-methoxy-7-(4-morpholinobut-2-yn-1-yloxy)quinazoline hydrochloride hydrate
反応式
[Cl:1][N:2]([C:10]1[C:19]2[C:14](=[CH:15][C:16]([OH:22])=[C:17]([O:20][CH3:21])[CH:18]=2)[N:13]=[CH:12][N:11]=1)[C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[F:9].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[O:42]1[CH2:47][CH2:46][N:45]([CH2:48][C:49]#[C:50][CH2:51]O)[CH2:44][CH2:43]1.N(C(OCC)=O)=NC(OCC)=O.C(Cl)[Cl:66]>>[OH2:20].[ClH:1].[Cl:66][C:6]1[CH:7]=[CH:8][C:3]([NH:2][C:10]2[C:19]3[C:14](=[CH:15][C:16]([O:22][CH2:51][C:50]#[C:49][CH2:48][N:45]4[CH2:46][CH2:47][O:42][CH2:43][CH2:44]4)=[C:17]([O:20][CH3:21])[CH:18]=3)[N:13]=[CH:12][N:11]=2)=[C:4]([F:9])[CH:5]=1参加物
反応物 5
生成物 1
実験手順
4-(Chloro-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline (250 mg, 0.78 mmol), (prepared as described for the starting material in Example 2), and triphenylphosphine (512 mg, 1.9 mmol) were added to a stirred solution of 4-morpholino-2-butyn-1-ol (182 mg, 1.1 mmol), (J. Am. Chem. Soc. 1957, 79, 6184), in methylene chloride (4 ml) under argon. Diethyl azodicarboxylate (0.307 ml, 1.9 mmol) was added dropwise and the reaction mixture was stirred for 30 minutes at ambient temperature. Additional 4-morpholino-2-butyn-1-ol (60 mg, 0.39 mmol), triphenylphosphine (102 mg, 0.39 mmol) and followed by diethyl azodicarboxylate (61 μl, 0.39 mmol) were added and the mixture was stirred for a further 15 minutes at ambient temperature. The solvent was removed by evaporation and the residue was purified by column chromatography eluting with methylene chloride/acetonitrile/methanol (60/37/3 followed by 60/35/5 and 55/37/8). The resulting purified oil was dissolved in a mixture of methylene chloride and methanol and ethereal hydrogen chloride (1 ml of a 2.9M solution) was added. The volatiles were removed by evaporation, the solid residue suspended in ether and collected by filtration. The product was recrystallised from 2-propanol/methanol/ether, collected by filtration, washed with 2-propanol and ether and dried to give 4-(4-chloro-2-fluoroanilino)-6-methoxy-7-(4-morpholinobut-2-yn-1-yloxy)quinazoline hydrochloride hydrate (75 mg, 18%).
後処理
- additionwere added
- stirringthe mixture was stirred for a further 15 minutes at ambient temperature
- customThe solvent was removed by evaporation
- customthe residue was purified by column chromatography
- washeluting with methylene chloride/acetonitrile/methanol (60/37/3 followed by 60/35/5 and 55/37/8)
- customThe resulting purified oil
- dissolutionwas dissolved in a mixture of methylene chloride and methanol and ethereal hydrogen chloride (1 ml of a 2.9M solution)
- additionwas added
- customThe volatiles were removed by evaporation
- filtrationcollected by filtration
- customThe product was recrystallised from 2-propanol/methanol/ether
- filtrationcollected by filtration
- washwashed with 2-propanol and ether
- customdried
出典と根拠
- ORDレコード
- ord-e8f66be59d7d499480969cfb3c1c00a0
- 出典データセット
- uspto-grants-2011_05
- 特許番号
- USRE042353E1
反応ノート
読み込み中…